Worth reading
43Recurring
Scored from 4 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
1500000
Shares (potential shares)Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Acquisition and cancellation of paid stock options (stock acquisition rights)
発行・処分する株式数
26th Series: equivalent to 190,000 shares; 28th Series: equivalent to 100,000 shares; 33rd Series: equivalent to 1,200,000 shares acquired and cancelled. Total: equivalent to 1,490,000 shares. The remaining amount after cancellation of the 33rd Series is equivalent to 2,230,000 shares.
Terms of the stock acquisition rights
Exercise price
26th Series: ¥240 per share; 28th Series: ¥280 per share; 33rd Series: ¥108 per share. Adjustment provisions and floor: Not disclosed
Exercise period
26th Series: from 1 January 2025 to 31 March 2029; 28th Series: from 1 January 2026 to 31 March 2030; 33rd Series: from 1 January 2031 to 30 November 2031
Number of Stock Acquisition Rights
26th Series: 3,250 rights at allocation, 1,900 acquired and cancelled, 0 remaining. 28th Series: 2,000 rights at allocation, 1,000 acquired and cancelled, 0 remaining. 33rd Series: 34,300 rights at allocation, 12,000 acquired and cancelled, 22,300 remaining.
Categories and Number of Persons Covered
26th Series: 1 Company director, 1 Company executive officer and 4 Company employees. 28th Series: 1 outside Company director and 1 Company executive officer. 33rd Series: 2 Company directors, 3 Company executive officers and 7 Company employees.
Impact on Business Performance
The impact of this matter on the Company's results is immaterial.
| Item | Details |
|---|---|
| Type of issuance or disposal | Acquisition and cancellation of paid stock options (stock acquisition rights) |
| Number of shares to be issued or disposed of | 26th Series: equivalent to 190,000 shares; 28th Series: equivalent to 100,000 shares; 33rd Series: equivalent to 1,200,000 shares acquired and cancelled. Total: equivalent to 1,490,000 shares. The remaining amount after cancellation of the 33rd Series is equivalent to 2,230,000 shares. |
| Exercise price | 26th Series: ¥240 per share; 28th Series: ¥280 per share; 33rd Series: ¥108 per share. Adjustment provisions and floor: Not disclosed |
| Exercise period | 26th Series: from 1 January 2025 to 31 March 2029; 28th Series: from 1 January 2026 to 31 March 2030; 33rd Series: from 1 January 2031 to 30 November 2031 |
| Number of Stock Acquisition Rights | 26th Series: 3,250 rights at allocation, 1,900 acquired and cancelled, 0 remaining. 28th Series: 2,000 rights at allocation, 1,000 acquired and cancelled, 0 remaining. 33rd Series: 34,300 rights at allocation, 12,000 acquired and cancelled, 22,300 remaining. |
| Categories and Number of Persons Covered | 26th Series: 1 Company director, 1 Company executive officer and 4 Company employees. 28th Series: 1 outside Company director and 1 Company executive officer. 33rd Series: 2 Company directors, 3 Company executive officers and 7 Company employees. |
| Impact on Business Performance | The impact of this matter on the Company's results is immaterial. |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The exercise prices are significantly higher than the current share price, making exercise extremely unlikely; the holdings of the departing holders no longer serve their original grant purpose; and reducing potential shares will ease shareholders' concerns about future dilution and simplify and clarify the capital structure.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.